Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001298963 | SCV001488034 | likely benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2022-11-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002541876 | SCV003749382 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.5360G>A (p.R1787Q) alteration is located in exon 36 (coding exon 36) of the RELN gene. This alteration results from a G to A substitution at nucleotide position 5360, causing the arginine (R) at amino acid position 1787 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |